Microfluidics-Enabled Antibody Discovery: Expediting Cancer and Immunology Research
Summary of Recent Advances in Microfluidic-Assisted Antibody Screening
Discover how Cyto-Mine® technology by Sphere Fluidics enhances antibody discovery with speed and precision. This 2021 study, published in mAbs, highlights how our microfluidics technology supports direct screening of antibody-secreting cells, providing rapid identification of therapeutic candidates in just weeks.
Research highlights
- Study Title: Versatile and Rapid Microfluidics-Assisted Antibody Discovery
- Authors: Ramona Gaa, Emmanuel Menang-Ndi, Shruti Pratapa, Christine Nguyen, Satyendra Kumar, Achim Doerner
- Published In: mAbs Journal, 2021
- DOI: 10.1080/19420862.2021.1978130
Key findings
- High Throughput and Precision: By using Cyto-Mine®, researchers screened up to two million droplets, identifying viable antibody-secreting cells with great efficiency.
- Functional Screening: This method supports functional IgG antibody screening, allowing the identification of cancer and immune disease antibodies with improved speed.
- Antibody Development in Record Time: The Cyto-Mine® process—from cell preparation to antibody confirmation—was completed in four weeks, highlighting its impact on streamlining therapeutic development timelines.
Additional Highlights
- Streamlined Workflow: Microfluidics allows efficient screening for functionality in droplets, making Cyto-Mine® ideal for labs focusing on immune and cancer therapeutics.
- Innovative Screening Capabilities: Researchers demonstrated functional antibody screening, which could support the development of therapeutic antibodies for diseases that are difficult to treat, including cancer and autoimmune diseases.
Why Cyto-Mine®?
Learn how Cyto-Mine® supports leading-edge research in antibody discovery, enabling scientists to isolate the best candidates with precision and efficiency. Visit our Cyto-Mine® product page to explore the technology that is empowering today’s breakthroughs in biotherapeutics.
The Next Generation: Cyto-Mine® Chroma
Automate. Accelerate. Analyze millions of cells in a single day.
Think Cyto-Mine®, but supercharged, enabling multiplexing and greater assay flexibility to fit your needs. It means that you can examine vastly greater numbers of cells — and isolate the most valuable ones— with unparalleled precision.
Cyto-Mine® Chroma
Contact sales
